Volume 66, Issue 1, Pages (January 2017)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 66, Issue 2, Pages (February 2017)
Volume 46, Issue 3, Pages (March 2007)
The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis  Padmavathi devi Nalapareddy, Sven Schüngel,
Depletion of Apoptosis Signal-Regulating Kinase 1 Prevents Bile Duct Ligation–Induced Necroinflammation and Subsequent Peribiliary Fibrosis  Hirotsugu.
Volume 58, Issue 6, Pages (June 2013)
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Volume 139, Issue 4, Pages e4 (October 2010)
Hepatitis induced by Kava (Piper methysticum rhizoma)
Volume 125, Issue 3, Pages (September 2003)
Volume 123, Issue 5, Pages (November 2002)
Volume 62, Issue 3, Pages (March 2015)
Volume 123, Issue 4, Pages (October 2002)
Reactive oxygen species in the normal and acutely injured liver
The management of childhood liver diseases in adulthood
Volume 129, Issue 2, Pages (August 2005)
Volume 53, Issue 5, Pages (November 2010)
Volume 139, Issue 4, Pages e4 (October 2010)
Volume 64, Issue 1, Pages (January 2016)
Volume 123, Issue 4, Pages (October 2002)
Volume 130, Issue 2, Pages (February 2006)
Volume 58, Issue 6, Pages (June 2013)
Volume 62, Issue 4, Pages (April 2015)
Volume 64, Issue 3, Pages (March 2016)
Volume 66, Issue 4, Pages (April 2017)
Volume 42, Issue 6, Pages (June 2005)
Volume 44, Issue 4, Pages (April 2006)
Volume 44, Issue 5, Pages (May 2006)
Volume 129, Issue 5, Pages (November 2005)
Volume 129, Issue 2, Pages (August 2005)
Hepatitis C core protein – The “core” of immune deception?
Volume 42, Issue 4, Pages (April 2005)
Volume 62, Issue 5, Pages (May 2015)
Volume 60, Issue 6, Pages (June 2014)
Volume 42, Issue 2, Pages (February 2005)
Volume 69, Issue 2, Pages (August 2018)
Volume 39, Issue 4, Pages (October 2003)
Volume 84, Issue 5, Pages (November 2013)
Volume 39, Issue 4, Pages (October 2003)
Volume 141, Issue 1, Pages e4 (July 2011)
Volume 61, Issue 6, Pages (December 2014)
Volume 53, Issue 5, Pages (November 2010)
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Volume 135, Issue 2, Pages (August 2008)
Volume 62, Issue 6, Pages (June 2015)
Volume 138, Issue 7, Pages (June 2010)
Volume 123, Issue 4, Pages (October 2002)
Volume 42, Issue 3, Pages (March 2005)
Volume 39, Issue 5, Pages (November 2003)
Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury  Rita Manco, Laure-Alix.
Volume 127, Issue 1, Pages (July 2004)
Volume 127, Issue 3, Pages (September 2004)
Volume 59, Issue 2, Pages (August 2013)
Volume 62, Issue 6, Pages (June 2015)
Volume 41, Issue 6, Pages (December 2004)
Liver stem cells—prospects for clinical use
Volume 44, Issue 2, Pages (February 2006)
Volume 118, Issue 1, Pages (January 2000)
Volume 50, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 64, Issue 6, Pages (June 2016)
Volume 61, Issue 6, Pages (December 2014)
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Volume 70, Issue 6, Pages (June 2019)
Volume 60, Issue 1, Pages (January 2014)
Pathogenesis of cholestatic hepatitis C
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
Volume 71, Issue 1, Pages (July 2019)
Genetics of hepatocellular carcinoma: The next generation
Presentation transcript:

Volume 66, Issue 1, Pages 95-101 (January 2017) Metabolic preconditioning protects BSEP/ABCB11−/− mice against cholestatic liver injury  Claudia D. Fuchs, Gustav Paumgartner, Annika Wahlström, Philipp Schwabl, Thomas Reiberger, Nadja Leditznig, Tatjana Stojakovic, Nataliya Rohr-Udilova, Peter Chiba, Hanns-Ulrich Marschall, Michael Trauner  Journal of Hepatology  Volume 66, Issue 1, Pages 95-101 (January 2017) DOI: 10.1016/j.jhep.2016.08.017 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2017 66, 95-101DOI: (10.1016/j.jhep.2016.08.017) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 BSEP−/− mice are protected against cholestatic liver injury induced by bile duct ligation and DDC feeding. (A and B) Representative H&E images (10× magnification) with apparently unremarkable liver histology in BSEP−/− mice before and after (A) CBDL and (B) DDC feeding. While BSEP−/− mice are protected as indicated by normal liver histology, WT mice show inflammation and bile infarcts (A white arrow) after CBDL and (B) portal inflammation and fibrosis after DDC feeding. (C and D) Serum biochemistry after (C) CBDL and (D) DDC feeding with increased serum levels of ALT, alkaline phosphatase (AP) and BAs in WT mice but not in BSEP−/− mice. #Significant difference from WT control; ∗significant difference from WT CBDL; p<0.05. Statistical analysis was performed using one-way analysis of variance test followed by Student’s t test. Journal of Hepatology 2017 66, 95-101DOI: (10.1016/j.jhep.2016.08.017) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 BSEP−/− mice are protected against inflammation after CBDL and DDC feeding. (A and B) Real-time PCR was used to assess the mRNA expression of F4/80, Mcp1 and IL1β as markers of inflammation after (A) CBDL and (B) DDC feeding. In contrast to WT mice, BSEP−/− CBDL mice and DDC fed mice did not show increased expression levels of these inflammatory markers compared to the control group. Expression values were normalized against 36b4 levels and are shown relative to expression level in WT controls. #Significant difference from WT Ctrl; ∗significant difference from WT CBDL; p<0.05. Statistical analysis was performed using one-way analysis of variance test followed by Student’s t test. Journal of Hepatology 2017 66, 95-101DOI: (10.1016/j.jhep.2016.08.017) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 3 BSEP−/− mice do not express markers of hepatocellular and ductular proliferation after CBDL and DDC feeding. (A and B) Ki67 and CK19 immunohistochemistry (10× magnification) after (A) CBDL and (B) DDC feeding showed increased hepatocyte and cholangiocyte proliferation in challenged WT mice but not in BSEP−/− mice. (C and D) Quantification of Ki67 and CK19 positive cells revealed a significant increase in Ki76 and CK19 positive cells in WT mice after (C) CBDL and (D) DDC feeding. (E and F) Real-time PCR was used to assess the mRNA expression of CK19 and Cftr as markers for ductular proliferation, in (E) CBDL and (F) DDC fed animals. Expression levels of both markers were increased in WT mice by CBDL and DDC feeding, but remained unchanged in BSEP−/− mice. Expression values were normalized against 36b4 levels and are shown relative to expression level in unchallenged WT animals #Significant difference from WT Ctrl; ∗significant difference from WT CBDL; p<0.05. Statistical analysis was performed using one-way analysis of variance test followed by Student’s t test. Journal of Hepatology 2017 66, 95-101DOI: (10.1016/j.jhep.2016.08.017) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 4 BSEP−/− mice are protected against biliary fibrosis after CBDL and DDC feeding. (A and B) Representative Sirius Red staining images (10× magnification) show pronounced biliary fibrosis in WT mice after (A) CBDL and (B) DDC feeding. (C and E) Real-time PCR was used to assess the mRNA expression of fibrotic markers Col1a1, Col1a2 and Tgfβ. Expression levels of these markers were increased in WT mice due to CBDL and DDC feeding and not affected in BSEP−/− mice. Expression values were normalized against 36b4 levels and are shown relative to expression level in unchallenged WT animals. #Significant difference from WT Ctrl; ∗significant difference from WT CBDL; p<0.05. (D and F) OH-proline levels were assed in mice subjected to (D) CBDL and (F) DDC feeding. OH-proline did not change in BSEP−/− mice after (D) CBDL mice and (F) DDC feeding. In WT mice CBDL was followed by a 1.8-fold and DCC feeding by a 1.5-fold increase of OH-levels. #Significant difference from WT Ctrl; ∗significant difference from WT CBDL; p<0.05. Statistical analysis was performed using one-way analysis of variance test followed by Student’s t test. Journal of Hepatology 2017 66, 95-101DOI: (10.1016/j.jhep.2016.08.017) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 5 BSEP−/− mice are metabolically preconditioned with a hydrophilic bile acid pool. (A and B) Real-time PCR was used to assess the mRNA expression of Cyp2b10 and Cyp3a11. While Cyp2b10 remained normal at baseline in BSEP−/− mice mRNA levels of Cyp3a11 are elevated. After (A) CBDL Cyp2b10 was increased in BSEP−/− mice while Cyp3a11 remained unchanged. (B) DDC feeding did not affect Cyp2b10 and Cyp3a11 expression in BSEP−/− mice. Expression values were normalized against 36b4 levels and are shown relative to expression level in unchallenged WT animals. #Significant difference from WT control; ∗significant difference from WT CBDL; p<0.05. Statistical analysis was performed using one-way analysis of variance test followed by Student’s t test. Journal of Hepatology 2017 66, 95-101DOI: (10.1016/j.jhep.2016.08.017) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions